Tag | Content |
---|
EnhancerAtlas ID | HS060-19472 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:71297970-71298810 |
Target genes | Number: 10 | Name | Ensembl ID |
|
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SP2 | MA0516.2 | chr2:71298744-71298761 | GAGGGGGCGGGGGTTGA | - | 6.7 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_09481 | chr2:71289500-71308125 | CD14 | SE_10573 | chr2:71294328-71301563 | CD19_Primary | SE_11354 | chr2:71289657-71304207 | CD20 | SE_27398 | chr2:71294624-71301717 | Esophagus | SE_53923 | chr2:71297334-71300941 | Spleen | SE_59346 | chr2:71289943-71300709 | Ly3 | SE_60816 | chr2:71290095-71300515 | DHL6 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TGAGTCTGGG GCGGAGCCTG GGAATTCAGC CATCTGTGAC ACTGAGACAG CTAGCAAGTT 60 TGGACTAGAT GAGTTTGATG ACTGCAGAGG GAAAGACCTC CAAGACTTAG TCCCTGGTGT 120 CAAAACTGTC ATAATCTCAC CCAGTCTCAT GGCTTCAGTT GCCACCTACA AACTACAAAT 180 GTGTTGGAAG AGCACAGGGC TTTGGAGAGC TGCTGAGACC TTGGTTTGAA TCCCAGCTTT 240 GCTGCTCAGT ATCTGCGTAA CCCTGTGTAG GTTACTCACC TTCTCTAAGC CTCAGTTTCC 300 TCATTTGGAA AATGTGAATA GTAGCTACCT CAGAGTTGTT GGGAAAGTAA AATGGCATGA 360 TACATTGCAA AGTGGTTAGT ATAGAGCCTG ACCCATAAGC ACTCATTAAA TGTTAGCTAT 420 TATTTACTCC TGGTTCAGAT CTTTCTCCCA AGTTGCGGTA GCTCCAGCTA CTCCCTGGAC 480 ATATATGTGA GATGTTCTGC AGACACAGGC AAACCTCGTG TATACCAAAC CAAGCTTACC 540 TCTCTCCATC TCCCCTCACC TTGCCCCGCT GCCTGATCTT TCTGTTAAGA GCACTACTGC 600 CCTTCCAAGC TCCAAAGCTG GCATTGTTGA ATCCCCTCTT TCTTCTGTCC ATCCCCAGTC 660 CAGGTTGTTC TTATAACCAC AGCCTTCTGA GGGGTCATTG TGTGGGGAGA AAGGAGGACT 720 GGGGCTGGGT GAACAGGGTA TGGCCAGATG GGGAGAACAG GAATCAGGCA TCAGGAGGGG 780 GCGGGGGTTG AGAAAAGAGC TGGGGCTGGG GCTCTGCACA CTCGCTCACC TCCCGCGTGG 840
|